Medical Condition News

RSS

Ruthigen files IND Application to FDA for lead drug candidate RUT58-60

Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.

2 May 2014

Isis Pharmaceuticals reports final data from ISIS-APOCIIIRx Phase 2 study in patients with FCS

Isis Pharmaceuticals, Inc. announced the final data from its Phase 2 study of ISIS-APOCIIIRx as a monotherapy in patients with familial chylomicronemia syndrome, or FCS.

2 May 2014

Teen suicide clusters linked to newspaper reports

Heightened newspaper coverage after a suicide might have a significant impact on the initiation of some teenage suicide clusters, according to new research published in The Lancet Psychiatry journal.

2 May 2014

New research suggests that Kindlin-3 regulates 2 major hallmarks of breast cancer

A protein believed to be limited to the hematopoietic system, called Kindlin-3, has been identified as a major player in both the formation and spread of breast cancer to other organs.

2 May 2014

14th Plymouth Symposium focuses on issues relating to obesity, diabetes and metabolic syndrome

The 14th Plymouth Symposium on obesity, diabetes and metabolic syndrome, 'Diabesity', will take place at the Plymouth Postgraduate Medical Centre at Derriford Hospital, Plymouth, UK, on 22nd May 2014.

2 May 2014

Acorda gets FDA Complete Response Letter for PLUMIAZ Nasal Spray NDA

Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for PLUMIAZ (diazepam) Nasal Spray for the treatment of people with epilepsy who experience cluster seizures.

2 May 2014

New mobile apps to help manage chronic pain patients

Mobile medicine is helping chronic pain patients cope with and manage their condition thanks to new smartphone apps, which can track patients from a distance and monitor pain, mood, physical activity, drug side effects, and treatment compliance.

2 May 2014

Study suggests reasons for disparities in obesity rates between African-American and white women

A new study suggests the reasons for disparities in obesity rates between African-American and white women are far more complex than the usual go-to culprits of socioeconomics, fruit and vegetable intake, and exercise.

2 May 2014

ABCDE rule outlines warning signs of melanoma

It is estimated that one in five Americans will be diagnosed with skin cancer in the course of their lifetime, and one person dies from melanoma - the deadliest form of skin cancer - every hour.

2 May 2014

Newly discovered molecule provides drug target for controlling both asthma and cancerous tumor growth

A newly discovered molecule provides a new drug target for controlling both asthma-induced muscle thickening and cancerous tumor growth. This molecule, called "microRNA-10a," normally helps genes produce proteins or make copies of themselves, also play an important role in the growth or overgrowth of human airway smooth muscle cells and some forms of cancer.

2 May 2014

New research explores potential effects of Hass avocado consumption on emerging cardiovascular disease risk factors

New research exploring the potential effects of Hass avocado consumption on emerging cardiovascular disease (CVD) risk factors was presented at the American Society for Nutrition Scientific Sessions and Annual Meeting at Experimental Biology 2014 (EB).

2 May 2014

New findings show combination of statins and omega-3 fatty acid may potentially reduce cardiovascular risk

New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.

2 May 2014

Eye movement disorder increases as we age, study finds

Abnormal binocular vision, which involves the way eyes work together as a team, increases dramatically as we age, according to research from the University of Waterloo. The study also found a correlation between this condition, general health and antidepressant use.

2 May 2014

Mayo Clinic neuroscientists define subtype of Alzheimer's disease

Neuroscientists at Mayo Clinic in Florida have defined a subtype of Alzheimer's disease (AD) that they say is neither well recognized nor treated appropriately.

2 May 2014

Scientists find key information that may lead to new therapeutic approaches to epilepsy

A team of researchers from Sanford-Burnham Medical Research Institute (Sanford-Burnham) and SUNY Downstate Medical Center (SUNY Downstate) has found that deficiencies in hyaluronan, also known as hyaluronic acid or HA, can lead to spontaneous epileptic seizures.

2 May 2014

Study examines potential benefits of low fat diet on management of MS

People with multiple sclerosis who for one year followed a plant-based diet very low in saturated fat had much less MS-related fatigue at the end of that year - and significantly less fatigue than a control group of people with MS who didn't follow the diet, according to an Oregon Health & Science University study being presented today at the American Academy of Neurology's annual meeting in Philadelphia, Pa.

2 May 2014

Study: Asthma is associated with reduced bone mineral density

Some of the 26 million Americans with asthma may also be prone to bone loss. According to a study published today in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, there seems to be association between asthma and a decrease in bone mineral density.

2 May 2014

Second Genome, Pfizer partner to conduct microbiome research to gain new insights into obesity

Second Genome announced today that it has entered into an agreement with Pfizer Inc. to conduct extensive microbiome research in a large observational study aimed at gaining new insights into obesity and metabolic disease.

2 May 2014

New computational model rapidly assess therapy outcomes in prostate cancer patients with bone metastasis

A new computational model that simulates bone metastasis of prostate cancer has the potential to rapidly assess experimental therapy outcomes and help develop personalized medicine for patients with this disease, according to data published in Cancer Research, a journal of the American Association for Cancer Research.

2 May 2014

FDA approves Parion’s investigational new drug application for treatment of dry eye disease

Parion Sciences, a company dedicated to the development of novel treatments for ocular and pulmonary diseases, announced today that it has received acceptance from the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for P-321 Ophthalmic Solution for the treatment of dry eye disease.

2 May 2014

Medical Condition News

Ruthigen files IND Application to FDA for lead drug candidate RUT58-60

Isis Pharmaceuticals reports final data from ISIS-APOCIIIRx Phase 2 study in patients with FCS

Teen suicide clusters linked to newspaper reports

New research suggests that Kindlin-3 regulates 2 major hallmarks of breast cancer

14th Plymouth Symposium focuses on issues relating to obesity, diabetes and metabolic syndrome

Acorda gets FDA Complete Response Letter for PLUMIAZ Nasal Spray NDA

New mobile apps to help manage chronic pain patients

Study suggests reasons for disparities in obesity rates between African-American and white women

ABCDE rule outlines warning signs of melanoma

Newly discovered molecule provides drug target for controlling both asthma and cancerous tumor growth

New research explores potential effects of Hass avocado consumption on emerging cardiovascular disease risk factors

New findings show combination of statins and omega-3 fatty acid may potentially reduce cardiovascular risk

Eye movement disorder increases as we age, study finds

Mayo Clinic neuroscientists define subtype of Alzheimer's disease

Scientists find key information that may lead to new therapeutic approaches to epilepsy

Study examines potential benefits of low fat diet on management of MS

Study: Asthma is associated with reduced bone mineral density

Second Genome, Pfizer partner to conduct microbiome research to gain new insights into obesity

New computational model rapidly assess therapy outcomes in prostate cancer patients with bone metastasis

FDA approves Parion’s investigational new drug application for treatment of dry eye disease

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News